Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

Share Price is delayed by 15 minutes
Get Live Data
210.60    3.00 (1.45%)
Bid:
209.80
Ask:
210.20
Spread: 0.40 (0.191%)
Market Cap: £916.68m
KIE Live PriceLast checked at - London Stock Exchange

Intraday Kier Share Chart

Board Changes

30 Mar 2020 07:01

RNS Number : 9565H
Kier Group PLC
30 March 2020
Β 

Kier Group plc

Board Changes

Kier Group plc (the "Company" or the "Group") announces the appointments of Mr. Clive Watson and Dame Heather Rabbatts to its board of directors (the "Board") with immediate effect.

Clive Watson is currently a non-executive director of Breedon Group plc and discoverIE Group plc, where he is the Chair of the Audit and Risk Committee, having previously been a non-executive director of Spirax-Sarco Engineering plc, where he was the Senior Independent Director and the Chair of the Audit Committee. During his executive career, Clive was the Group Finance Director at Spectris plc from 2006-2019, having previously held a number of senior finance positions at Borealis, Thorn Lighting Group and The Black & Decker Corporation.

Clive will be the Chair of the Risk Management and Audit Committee and a member of the Nomination Committee, the Remuneration Committee and the Safety, Health and Environment Committee.

Justin Atkinson will stand down from the role of acting Chair of the Risk Management and Audit Committee with immediate effect and continue in the role of Senior Independent Director.

Heather Rabbatts has held a number of executive and non-executive positions in the local government, entertainment and sport sectors, in particular. Heather is currently the Chair of Soho Theatre Company and her recent non-executive directorships include Crossrail, the Football Association, where she was a member of the Remuneration Committee, and Grosvenor Britain & Ireland, where she was the Chair of the Audit Committee.

Heather will be the Chair of the Remuneration Committee and a member of the Nomination Committee, the Risk Management and Audit Committee and the Safety, Health and Environment Committee.

Constance Baroudel, the current Chair of the Remuneration Committee, will stand down from the Board with immediate effect.

Matthew Lester, Chairman, said: "We are delighted that Clive and Heather will be joining the Board. Both have a depth of experience which will be invaluable as the Board continues to oversee the delivery of the Group's strategic objectives. I look forward to working with Clive and Heather.

I would like to thank Constance for her contribution over almost four years on the Board. I would also like to thank Justin for undertaking the role of Chair of the Risk Management and Audit Committee on an interim basis.

As the Chair of the Remuneration Committee, Heather will be engaging with shareholders with respect to the Company's revised remuneration policy, which will assist her to understand the reasons for the significant vote against the Directors' Remuneration Report at the 2019 AGM and to consider any actions which may need to be taken as a result."

In relation to the appointment of Clive Watson, no further information is required to be disclosed pursuant to Listing Rule 9.6.13R.

In relation to the appointment of Heather Rabbatts, no information is required to be disclosed pursuant to Listing Rule 9.6.13R.

Β 

Further information

Please contact:

Β 

Kier Press OfficeΒ 

+44 (0)1767 355 096

Richard Mountain/Nick Hasell - FTI ConsultingΒ 

+44 (0)20 3727 1340

This announcement does not constitute an offer of securities by Kier Group plc (the "Company"). Nothing in this announcement is intended to be, or intended to be construed as, a profit forecast or a guide as to the performance, financial or otherwise, of the Company or any of its subsidiaries (together, the "Group") whether in the current or any future financial year. This announcement may include statements that are, or may be deemed to be, ''forward-looking statements''. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond the Company's or the Group's ability to control or predict. Forward-looking statements are not guarantees of future performance. You are advised to read the section headed ''Principal risks and uncertainties'' in the Company's Annual Report and Accounts for the year ended 30 June 2019 and the Company's results announcement for the six months ended 31 December 2019 for further information about the factors that could affect the Company's or the Group's future performance and the industry in which it operates. Other than in accordance with its legal or regulatory obligations, the Company does not accept any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
BOAMZGZFRLKGGZM
Date   Source Headline
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20254:13 pmRNSDirector/PDMR Shareholding
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20255:06 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20253:45 pmRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSResults for the period ended 31 December 2024
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20254:34 pmRNSHolding(s) in Company
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 202510:21 amRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 20255:05 pmRNSHolding(s) in Company
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20251:18 pmRNSDirector/PDMR Shareholding
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20257:00 amRNSTransaction in Own Shares
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
13th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 202510:45 amRNSTotal Voting Rights
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.